David D Chang
CIK 1611024 · President and CEO · last filed 2026-03-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$11.41M
Companies
2
Total Filings
46
Lifetime Open-Market Net
-$15.90M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALLO | President and CEO | 6,006,643 | $1.90 | $11.41M | -$1.10M | 30 | 2026-03-18 |
| Kite Pharma, Inc. (KITE) Delisted | EVP, R&D, Chief Medical Off. | 65,350 | — | — | -$14.80M | 15 | 2017-09-27 |
Recent Filings · Page 5 of 5
46 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-10-02 | Kite Pharma, Inc. (KITE) Delisted | Mixed | — | -$371.3K | EDGAR |
| 2015-09-08 | Kite Pharma, Inc. (KITE) Delisted | Mixed | — | -$370.4K | EDGAR |
| 2015-08-04 | Kite Pharma, Inc. (KITE) Delisted | Mixed | — | -$502.2K | EDGAR |
| 2015-07-02 | Kite Pharma, Inc. (KITE) Delisted | Mixed | — | -$423.7K | EDGAR |
| 2015-06-17 | Kite Pharma, Inc. (KITE) Delisted | Mixed | +4,000 | -$317.7K | EDGAR |
| 2014-12-30 | Kite Pharma, Inc. (KITE) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 41–46 of 46
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.